Please assess the completion status of the following clinical trial:

Trial Title: Investigate Risperidone for the Treatment of Schizophrenia in Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A responsible person must be available to accompany the subject to the site at each visit~* patient must meet the DSM-IV criteria for schizophrenia~Exclusion Criteria:~* Patients with mild, moderate or severe mental retardation~* patients with a known or suspected history of substance dependence~* subjects weighing \<35kg~* subjects who cannot swallow oral tablets

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).